10/5 Late treatment study
et al., Journal of Microbiology, Immunology and Infection, doi:10.1016/j.jmii.2020.09.003 (Peer Reviewed)
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
Small case study of 5 patients in Japan showing improvement with HCQ+AZ+ciclesonide.
Mori et al., 10/5/2020, peer-reviewed, 3 authors.
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All
practical, effective, and safe means should be used. Elimination of COVID-19
is a race against viral evolution. No treatment, vaccine, or intervention is
100% available and effective for all current and future variants. Denying the
efficacy of any method increases the risk of COVID-19 becoming endemic; and
increases mortality, morbidity, and collateral damage. We do not provide
medical advice. Before taking any medication, consult a qualified physician
who can provide personalized advice and details of risks and benefits based
on your medical history and situation. Treatment protocols for physicians are
available from the FLCCC.